GENETIC TECHNOLOGIES LIMITED (GTG)



Welcome to InvestSMART

You are currently viewing our site as a guest, which gives you limited access to our site features. By signing up for a free membership, you will receive our Investment Opportunity newsletters and have access to additional features for finding and comparing managed funds and shares. Registration is fast and simple, so please:

Sign Up Today » it's FREE! Already a member? Login now!


General Information
Company Name: Genetic Technologies Limited
Stock Code: GTG
Website: www.gtglabs.com.au
GICS Sub-Industry: Biotechnology
Market Cap ($M): 41
Equiv. Shares (M): 475

Current Price Data+
Current Price Open High Low Last Close Volume Price Movement
 $ 0.099 $ 0.097 $ 0.099 $ 0.095 $ 0.086 823,646 $ 0.013  15.116 %

Current Broker Consensus Recommendation more
Recommendation: Hold
Recommendation Date: 30th Aug 2005
12 Month Target Price (average): $0
Brokers Surveyed: 0

Company Overview

Business Description:
Genetic Technologies Limited (GTG) is a biotechnology company engaged in genetic testing service business, licensing international patents and conducting research activities on the impact of DNA on health. GTG has operations in Australia, China, Canada, Switzerland and USA. Its primary focus is diagnostic products for cancer management. GTG provides genetic tests products & services in three areas: Medical, Profiling and Animal.


Financial Summary
Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2012  A -10.4 -2.3 NaN 0.0 0.0 0.0 --
2011  A 0.9 0.2 -- 37.1 0.0 0.0 --
2010  A -8.1 -2.1 -- 0.0 0.0 0.0 --
Source: Morningstar analyst estimates.

Peer Comparison
EPS Growth (%) P/E (%) Dividend Yield (%)
Company Mkt Cap 2010 A 2011 F 2012 F 2010 A 2011 F 2012 F 2010 A 2011 F 2012 F
CSL (CSL) $30,453 M 0.0878 0.3215 0.1438 32.6608 24.7155 21.6080 0.0135 0.0170 0.0192
Genetic Technologies (GTG) $45 M -- -- -- -- -- -- 0.0000 -- --
Mesoblast (MSB) $1,716 M -- -- -- -- -- -- 0.0000 0.0000 0.0000
Starpharma (SPL) $237 M -- -- -- -- -- -- 0.0000 0.0000 0.0000
Sirtex Medical (SRX) $606 M 0.4803 0.9043 0.3573 35.9603 18.8837 13.9124 0.0092 0.0176 0.0235

Market Comparison
Earnings P/E Ratio P/B Ratio P/E Growth P/S Ratio
GTG -- -- 2.80 -- 6.37
Market 1.13 13.2 0.92 2.50 2.58
Sector 0.65 21.3 2.39 0.55 6.49

Directors
Name Position Start Date
Mr Tommas Bonvino Non-Executive Director 25 November 2009
Dr Mervyn Cass Non-Executive Director 30 September 2011
Mr Benjamin Silluzio Non-Executive Director 10 December 2012
Dr Malcolm Roy Brandon Non-Executive Director,Non-Executive Chairman 05 October 2009

Management
Name Position
Paul D.R. MacLeman Chief Executive Officer
Thomas G Howitt Chief Finance Officer,Company Secretary
Alison Mew Chief Operating Officer,Acting Chief Executive Officer
Ivan Jasenko Quality and Regulatory Manager
Mark J. Ostrowski Senior Vice President Sales and Marketing
David J. Sparling Vice President Legal and Corporate Development
Gregory J. McPherson Vice President Sales and Marketing

Substantial Shareholders
Holding Name
136,473,684 (29.37%) Mervyn Jacobson

Calendar of Events
Date Event
25 February 2014 Report (Interim)
21 February 2014 Report (Interim)
24 October 2013 Report (Annual)
17 October 2013 Report (Annual)
27 August 2013 Report (Prelim)
© 2011 Morningstar, Inc. All rights reserved. The data and content contained herein are not guaranteed to be accurate, complete or timely. Neither Morningstar, nor its affiliates nor their content providers will have any liability for use or distribution of any of this information. To the extent that any of the content above constitutes advice, it is general advice that has been prepared by Morningstar Australasia Pty Ltd ABN: 95 090 665 544, AFSL: 240892 (a subsidiary of Morningstar, Inc.), without reference to your objectives, financial situation or needs. Before acting on any advice, you should consider the appropriateness of the advice and we recommend you obtain financial, legal and taxation advice before making any financial investment decision. If applicable investors should obtain the relevant product disclosure statement and consider it before making any decision to invest. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). DISCLOSURE: Employees may have an interest in the securities discussed in this report. Please refer to our Financial Services Guide (FSG) for more information at www.morningstar.com.au/fsg.asp.

Advertisement

Trade Shares Online from $19.95^
Free Guides

The SMH Guide to Investing in Property through Super

An educational booklet on running your own superannuation fund and investing in property.

More details...

News

How much more bull can world markets bear?

The Age 20/05/2013 | It is getting virtually impossible to find an expert who believes global equity markets are a risky place to invest. As markets on all continents grind higher and higher, the bears are in danger of becoming extinct and the Winston Churchill "voice in the wilderness" warning us of the troubles ahead seems to have departed the scene. When everyone is in agreement, we should start to get a little worried.

Tiger Australia cuts its losses

The Age 20/05/2013 | Tiger Australia has continued to narrow its losses due to stronger returns from fares and is operating without restrictions from air-safety authorities.

It takes no brains to kick Treasury

The Age 20/05/2013 | When it comes to forecasting the economy - and thereby the budget balance - the econocrats of the Reserve Bank and Treasury are on a hiding to nothing.

Monopoly delivered on a platter

The Age 20/05/2013 | Markets ought to be about competition. To quote historian Niall Ferguson, they should ensure the survival of the fittest, not the fattest.

Morgan Stanley sued over $5m super losses

The Age 20/05/2013 | Investment bank Morgan Stanley Smith Barney is being sued after losing more than $5 million from the super accounts of two private clients with a series of "aggressive, highly speculative and high-risk" trades using derivatives and share options.

How much more bull can world markets bear?

Sydney Morning Herald 20/05/2013 | It is getting virtually impossible to find an expert who believes global equity markets are a risky place to invest. As markets on all continents grind higher and higher, the bears are in danger of becoming extinct and the Winston Churchill "voice in the wilderness" warning us of the troubles ahead seems to have departed the scene. When everyone is in agreement, we should start to get a little worried.

More...


Sponsored Links

Feedback Form